Literature DB >> 23369185

Naphthalimide derivatives with therapeutic characteristics: a patent review.

Ahmed Kamal1, Narasimha Rao Bolla, Pandala Sindayla Srikanth, Ajay Kumar Srivastava.   

Abstract

INTRODUCTION: Naphthalimides are important aromatic heterocycles with immense pharmacological significance as they serve as core scaffold for many antitumor, anti-inflammatory, antidepressant, antiprotozoal and antiviral agents, etc. The tricyclic planar ring system of naphthalimide is primarily responsible for its intercalation with DNA to perturb the cellular events and the substitution pattern of the molecule leads to several other applications. The promising pharmacological activity profile and ease of synthesis have been attractive in design and development of new class of naphthalimides and their conjugates as various potential therapeutic agents. Few of such molecules are currently under preclinical and clinical evaluations. AREAS COVERED: Important patents focusing on naphthalimides as potential class of therapeutics, published between the period of 2006 - 2011 have been covered. The reports are presented together with a review of the related structural chemical space. This review mainly focuses on the therapeutic applications, structural modifications of naphthalimide scaffold, their conjugates and heterocyclics bearing naphthalimide moiety. EXPERT OPINION: The tricyclic planar ring system of naphthalimide restrains important pharmaceutical properties along with excellent fluorescent after proper substitution pattern. Linking these active naphthalimide derivatives with other active pharmacophore has become an interesting area of research. The utility of naphthalimide derivatives as novel pharmaceutical and photochemical agents can be further enhanced by introducing polar side chains and fusing functionalized heterocyclic rings with naphthalimide cores.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23369185     DOI: 10.1517/13543776.2013.746313

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  12 in total

1.  Design of DNA Intercalators Based on 4-Carboranyl-1,8-Naphthalimides: Investigation of Their DNA-Binding Ability and Anticancer Activity.

Authors:  Sebastian Rykowski; Dorota Gurda-Woźna; Marta Orlicka-Płocka; Agnieszka Fedoruk-Wyszomirska; Małgorzata Giel-Pietraszuk; Eliza Wyszko; Aleksandra Kowalczyk; Paweł Stączek; Katarzyna Biniek-Antosiak; Wojciech Rypniewski; Agnieszka B Olejniczak
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

2.  Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.

Authors:  Sebastian Rykowski; Dorota Gurda-Woźna; Marta Orlicka-Płocka; Agnieszka Fedoruk-Wyszomirska; Małgorzata Giel-Pietraszuk; Eliza Wyszko; Aleksandra Kowalczyk; Paweł Stączek; Andrzej Bak; Agnieszka Kiliszek; Wojciech Rypniewski; Agnieszka B Olejniczak
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

3.  A crystal structure-guided rational design switching non-carbohydrate inhibitors' specificity between two β-GlcNAcase homologs.

Authors:  Tian Liu; Peng Guo; Yong Zhou; Jing Wang; Lei Chen; Huibin Yang; Xuhong Qian; Qing Yang
Journal:  Sci Rep       Date:  2014-08-26       Impact factor: 4.379

4.  A novel triazolonaphthalimide induces apoptosis and inhibits tumor growth by targeting DNA and DNA-associated processes.

Authors:  Liyan Ji; Simin Yang; Shasha Li; Shan Liu; Shunan Tang; Zhongqiu Liu; Xiangbao Meng; Siwang Yu
Journal:  Oncotarget       Date:  2017-06-06

5.  Discovery of novel phthalimide analogs: Synthesis, antimicrobial and antitubercular screening with molecular docking studies.

Authors:  Heba S Rateb; Hany E A Ahmed; Sahar Ahmed; Saleh Ihmaid; Tarek H Afifi
Journal:  EXCLI J       Date:  2016-12-06       Impact factor: 4.068

6.  Synthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates.

Authors:  Iwona E Głowacka; Rafał Gulej; Piotr Grzonkowski; Graciela Andrei; Dominique Schols; Robert Snoeck; Dorota G Piotrowska
Journal:  Molecules       Date:  2016-10-26       Impact factor: 4.411

7.  Design, Synthesis and Evaluation of Naphthalimide Derivatives as Potential Anticancer Agents for Hepatocellular Carcinoma.

Authors:  Chaochao Ge; Liping Chang; Ying Zhao; Congcong Chang; Xiaojuan Xu; Haoying He; Yuxia Wang; Fujun Dai; Songqiang Xie; Chaojie Wang
Journal:  Molecules       Date:  2017-02-22       Impact factor: 4.411

8.  Synthesis, Antitumor and Antibacterial Studies of New Shortened Analogues of (KLAKLAK)2-NH2 and Their Conjugates Containing Unnatural Amino Acids.

Authors:  Sirine Jaber; Ivan Iliev; Tsvetelina Angelova; Veronica Nemska; Inna Sulikovska; Emilia Naydenova; Nelly Georgieva; Ivan Givechev; Ivo Grabchev; Dancho Danalev
Journal:  Molecules       Date:  2021-02-08       Impact factor: 4.411

9.  Naphthalimide-Containing BP100 Leads to Higher Model Membranes Interactions and Antimicrobial Activity.

Authors:  Gustavo Penteado Battesini Carretero; Greice Kelle Viegas Saraiva; Magali Aparecida Rodrigues; Sumika Kiyota; Marcelo Porto Bemquerer; Hernan Chaimovich; Iolanda Midea Cuccovia
Journal:  Biomolecules       Date:  2021-04-08

10.  Novel Synthetic Approaches for Bisnaphthalimidopropyl (BNIP) Derivatives as Potential Anti-Parasitic Agents for the Treatment of Leishmaniasis.

Authors:  Elif Keskin; Mehmet Hikmet Ucisik; Bilgesu Onur Sucu; Mustafa Guzel
Journal:  Molecules       Date:  2019-12-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.